Skip to content

Industry Event

PHUSE’s Innovations and Strategies in Biometrics and their Impact on Pharma

Innovation propels companies forward. It’s an unlimited source of new growth and can give businesses a distinct competitive advantage. The pharmaceutical industry is fundamentally a data-driven business. All along the value chain from research to market, we wrap our molecules around with data to prove their mode of action, their safety, and efficacy, and eventually to inform healthcare practitioners on how to best use them when treating patients to improve or extend their lives. During this process we come across many innovative ideas, strategies and their benefits. The importance of innovative ideas and strategies is the way to become future-proof. We are living in unprecedented times for data – and innovative digital disruption and life sciences & biometrics are no exception.

TransCelerate’s Min Lee (Amgen) will be presenting on the Modernization of Statistical Analytics initiatives.